5jf5: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT020== | ==Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT020== | ||
<StructureSection load='5jf5' size='340' side='right' caption='[[5jf5]], [[Resolution|resolution]] 1.80Å' scene=''> | <StructureSection load='5jf5' size='340' side='right'caption='[[5jf5]], [[Resolution|resolution]] 1.80Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5jf5]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JF5 OCA]. For a <b>guided tour on the structure components</b> use [ | <table><tr><td colspan='2'>[[5jf5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Streptococcus_agalactiae Streptococcus agalactiae]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JF5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5JF5 FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=7JT:(3R)-3-{3-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-1,2,4-OXADIAZOL-5-YL}-4-CYCLOPENTYL-N-HYDROXYBUTANAMIDE'>7JT</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene>, <scene name='pdbligand= | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.8Å</td></tr> | ||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=7JT:(3R)-3-{3-[(2H-1,3-BENZODIOXOL-5-YL)METHYL]-1,2,4-OXADIAZOL-5-YL}-4-CYCLOPENTYL-N-HYDROXYBUTANAMIDE'>7JT</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene>, <scene name='pdbligand=OCS:CYSTEINESULFONIC+ACID'>OCS</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5jf5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5jf5 OCA], [https://pdbe.org/5jf5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5jf5 RCSB], [https://www.ebi.ac.uk/pdbsum/5jf5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5jf5 ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | == Function == | ||
[ | [https://www.uniprot.org/uniprot/DEF_STRA3 DEF_STRA3] Removes the formyl group from the N-terminal Met of newly synthesized proteins. Requires at least a dipeptide for an efficient rate of reaction. N-terminal L-methionine is a prerequisite for activity but the enzyme has broad specificity at other positions. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 24: | Line 23: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: | [[Category: Large Structures]] | ||
[[Category: Streptococcus agalactiae]] | [[Category: Streptococcus agalactiae]] | ||
[[Category: | [[Category: Fieulaine S]] | ||
[[Category: Giglione C]] | |||
[[Category: Meinnel T]] | |||
Latest revision as of 11:01, 6 September 2023
Crystal structure of type 2 PDF from Streptococcus agalactiae in complex with inhibitor AT020
| ||||||||||||
